e-learning
resources
Munich 2006
Sunday 03.09.2006
Screening, diagnosis, staging, prognosis, biological features
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Do cavitating non-small cell lung cancer patients have a more aggressive disease?
M. B. Cekic, M. H. Rancic (Nis, Serbia And Montenegro)
Source:
Annual Congress 2006 - Screening, diagnosis, staging, prognosis, biological features
Session:
Screening, diagnosis, staging, prognosis, biological features
Session type:
E-Posters in free access
Number:
579
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. B. Cekic, M. H. Rancic (Nis, Serbia And Montenegro). Do cavitating non-small cell lung cancer patients have a more aggressive disease?. Eur Respir J 2006; 28: Suppl. 50, 579
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
How to handle oligometastatic disease in nonsmall cell lung cancer
Source: Eur Respir Rev, 30 (159) 200234; 10.1183/16000617.0234-2020
Year: 2021
Metastatic disease in non-small cell lung cancer: is it all the same?
Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up
Year: 2017
Management of brain metastases in patients with non-small cell lung cancer
Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside
Year: 2017
A modified ILD-GAP index for patients with non-small cell lung cancer and interstitial lung disease
Source: International Congress 2018 – Lung cancer: personalised medicine
Year: 2018
Detecting extrathoracic metastases in patients with non-small cell lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 41s
Year: 2006
Advanced non-small cell lung cancer in elderly patients
Source: Breathe 2012; 9: 26-34
Year: 2012
Radio(chemo)therapy in locally advanced nonsmall cell lung cancer
Source: Eur Respir Rev 2015; 25: 65-70
Year: 2016
Early recurrence in complete resected non-small cell lung cancer patients
Source: International Congress 2017 – Lung cancer: important scientific reports from endoscopists and thoracic surgeons
Year: 2017
Real-life experience of ceritinib in crizotinib-pretreated
ALK
+
advanced non-small cell lung cancer patients
Source: ERJ Open Res, 4 (1) 00058-2017; 10.1183/23120541.00058-2017
Year: 2018
Delays in the diagnosis and treatment of non-small cell lung cancer
Source: Annual Congress 2010 - Quality management for lung cancer patients
Year: 2010
Management of patients with non-small-cell lung cancer
Source: ERS Live 2007
Year: 2007
Possibility of the specific efficacy of gefitinib for miliary lung metastasis in non-small cell lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 303s
Year: 2004
Surgery for elderly early-stage non-small cell lung cancer: less or more?
Source: International Congress 2019 – All aspects of general thoracic surgery
Year: 2019
Clinicopathologic features of patients with non-small cell lung cancer and chronic obstructive pulmonary disease undergoing lung cancer surgery
Source: Virtual Congress 2020 – Localised non-small cell lung cancer
Year: 2020
Bronchoscopic treatment of inoperable nonsmall cell lung cancer
Source: Eur Respir Rev, 29 (158) 200035; 10.1183/16000617.0035-2020
Year: 2020
A study on chemotherapy induced interstitial lung disease in patients with unresectable non-small cell lung cancer complicated by combined pulmonary fibrosis and emphysema
Source: Annual Congress 2012 - Treatment of lung cancer
Year: 2012
Our experience with crizotinib in the treatment of non-small cell lung cancer
Source: Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer
Year: 2020
Lobectomy should remain the first choice for treating early stage nonsmall cell lung cancer
Source: Eur Respir J, 54 (1) 1900649; 10.1183/13993003.00649-2019
Year: 2019
The method of individualisation of treatment and prognosis for advanced non-small cell lung cancer
Source: Annual Congress 2010 - Prognostic factors for lung cancer
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept